Weighing more GLP-1 drug concerns
Update on patients quitting, costs, access
Related Articles
New Alzheimer’s test: The coverage vs. context
When the FDA recently approved the Lumipulse blood test to help with diagnose of Alzheimer’s Disease, there was the usual roundup of hyperbole which can…
Bernie wants drug ads banned. He’s not alone.
Two independent US Senators, Bernie Sanders and Angus King, have introduced the End Prescription Drug Ads Now Act that would ban prescription drug ads on…
Bernie wants drug ads banned. He’s not alone.
Two independent US Senators, Bernie Sanders and Angus King, have introduced the End Prescription Drug Ads Now Act that would ban prescription drug ads on…
Too much glitz, too little evidence, in full body scan stories
How new screening tests get free and glowing publicity
Too much glitz, too little evidence, in full body scan stories
How new screening tests get free and glowing publicity
Why People May Stop Using GLP-1 Drugs
How many people stop using GLP-1 drugs and why is not an unreported phenomenon, but I think it is under-reported in mainstream news media coverage…
Gary Schwitzer’s HealthNewsReview Substack | Substack
My HealthNewsReview.org website, published daily for 16 years, is gone. But here I’ll weigh in on health care news, especially when I see a way…
Do ultra-processed foods kill 124,000 Americans yearly?
When a paper in the American Journal of Preventive Medicine was published in April, headlines were consistent:
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have resulted in blindness, tumors and…